SCIENTIFIC PROGRAM


Day 1: (10-Jan-2025)
Session Time Topic Faculty Name
08:00 – 09:15 Quiz Prelims : All Teams Quiz Masters: Dr. Karthik Bomannam, Dr. VA Arun
Session 1: Integrating Myeloma Investigations into Clinical Practices Chairpersons: Dr. Mayur Parihar & Dr. Kunal Sehgal
09:15 – 09:20 Welcome Dr. Deepak Mishra
09:20 – 09:35 Making a Diagnosis of Multiple Myeloma Dr. Prashant Kapoor
09:40 – 09:55 Serum Electrophoresis Dr. Subhosmito Chakraborty
10:00 – 10:15 Approaches to Assessment of Minimal Residual Disease Dr. Nikhil Patker
10:20 – 10:35 Bone Imaging: Beyond Skeletal Surveys Dr. Chandramouli Nagarajan
10:40 – 10:55 Circulating Tumor Cells and Circulating DNA Status and Biomarkers Dr. Prashant Tembhare
Session 2: Multiple Myeloma: Initial Diagnosis and Treatment Chairpersons: Dr. Subhash Varma; Dr. Sanjeevan Sharma
11:00 – 11:15 The Core Pillars of Myeloma Induction Therapy Dr. Shaji Kumar
11:20 – 11:35 Can Immune Signatures Predict Outcome in MM? Dr. Wee Joo
11:40 – 11:55 Best Consolidation/Maintenance Strategies Post ASCT Dr. Sundar Jagannath
12:00 – 12:20 Managing NDMM in Resource-Constrained Settings Dr. Lalit Kumar
12:20 – 13:00 Q & A Session on Diagnosis and Treatment of NDMM Moderator: Lt Gen (Dr) Velu Nair
Panelists: Dr. B K Smruti, Dr. Saurabh Bhave, Dr Ketan Modak, Dr. Biswajit Dubashi, Dr. Manish K Singh, Dr. Sreejesh Sreedharan.
Break 13:00 – 14:00 Lunch
Session 3: Transplant Ineligible/ Relapsed Refractory Multiple Myeloma Chairpersons: Dr. R K Jena, Dr. Suman Pramanik
14:00 – 14:15 Induction Treatment of Transplant Ineligible/Elderly NDMM Dr. Tapan Saikia
14:20 – 14:35 Approaches to Treatment of RRMM Excluding T-Cell Directed Therapy Dr. Chandramouli Nagarajan
14:40 – 14:55 Treatment of Relapse Post-Transplant/Role of Allo-HSCT in MM Dr. Anupam Chakrapani
15:00 – 15:15 New Drugs on the Horizon: Ongoing Clinical Trials for RRMM Dr. Sundar Jagannath
15:20 – 16:00 Challenges in Managing Relapse Refractory MM in India Moderator: Dr. Biju George
Panelists: Dr. Prakash Chitalkar, Dr. Chirag Shah, Dr. Subhaprakash Sanyal, Dr. Shyam Agarwal, Dr. Shilpa Gupta
16:00 – 16:30 Tea/Coffee
Session 4: Supportive Management in Myeloma Chairpersons: Dr. Maitrayee Bhattacharya & Dr. Govind Babu
16:30 – 16:45 Management of Renal Complications in MM Dr. Manu Dogra
16:50 – 17:05 Recommendations for Treatment of Myeloma Related Bone Disease: Drugs and Dosing Dr. Noopur Raje
17:10 – 17:25 Decreasing Infectious Complications in MM: Prophylaxis and Vaccination Dr. Priya Sampathkumar
17:30 – 17:45 Is There a Role of Radiotherapy in the Current Management of MM? Dr. Rimpa Achari
17:45 – 18:20 Adequate Pain Management and Quality of Life Issues in NDMM Moderator: Dr. Joseph John
Panelists: Dr. Arvind Mathur, Dr. Gaurav Prakash, Dr. Naved Tamboli, Dr. Smitha Saldana
Session 5: Indian Data Chairpersons: Dr. Suresh Advani, Dr. Prantar Chakrabarti
18:30 – 18:45 Artificial Intelligence in Myeloma Dr. Ritu Gupta
18:50 – 19:05 Low-Cost Screening of Monoclonal Gammopathies TBA
19:10 – 19:25 MALDI-TOF Mass Spectrometry for M Protein Analysis: from Bench to Bedside Dr. Nikita Mehra
19:30 – 19:45 Indigenous (Aurigene) BCMA CAR T Cell Results: Phase 1 Dr. Hari Menon
19:45 – 20:00 ------- -----
End of Day 1 : Dinner
Day 2: (11-Jan-2025)
Session Time Topic Faculty Name
08:00 - 10:20 Conversation with Myeloma Experts Case Presentors: Making sense of the Evolving treatment landscapes
Conference Room Seminar Room 1 Seminar Room 2
Management of complicated NDMM Dr. Sundar Jagannath/ Dr. Prashant Kapoor /Dr. Biju George Dr. Priya SampathKumar/ Dr. Noopur Raje/ Dr. Subhash Verma
Dr. Shaji K Kumar/ Dr. Nikhil Munshi/ Dr. Lalit Kumar Dr. Sundar Jagannath/ Dr. Prashant Kapoor/ Dr. Biju George Dr. Priya SampathKumar/ Dr. Noopur Raje/ Dr. Subhash Verma
Case 1: Dr Chirag Shah
Case 2: Dr Ashish Dixit
Case 1: TBD
Case 2: TBD
Case 1: Dr Rajat Pincha
Case 2: Dr Avinash Singh
Break 08:50 - 09:20 Breakfast
Related PCD Supportive care and Palliation Planning prospective trials in Myeloma/ PCD
Dr. Chandramaouli/ Dr. Sundar Jagannath/ Dr. Hemant Malhotra Dr. Shaji K Kumar/ Dr. Nikhil Munshi/ Dr. Joseph John Dr. Vincent Rajkumar/ Dr. Ashutosh Wachlekar/ Dr. Govind Babu
Case 1: Dr Rohith Chitrapur
Case 2: Dr Aditya Jandial
Case 1: TBD
Case 2: TBD
Case 1: TBD
Case 2: TBD
Session 1: Precursor Conditions: Overview and Therapeutic Intervention Chairpersons: Dr. Hemant Malhotra & Dr. Chepsy Philip
10:30 - 10:45 Identifying Patients with Myeloma Precursor Conditions: Lessons from iSTOPMM and PROMISE Study Dr. Shaji Kumar
10:50 - 11:05 Immune Progression from MGUS to SMM Dr. Nikhil Munshi
11:10 - 11:25 Can Intervention Prevent Progression in MM: Ongoing Clinical Trials for SMM Dr. Vincent Rajkumar
11:30 - 11:45 Risk stratification of Multiple Myeloma Dr. Samir Melinkari
11:50 - 12:30 Round Table Discussion on Precursor Disease Management in India Moderator: Dr. Hari Menon
Panelists: Dr. Ajay Gogia, Dr. Anil Handoo, Dr. Ashish Dixit, Dr. Tuphan Dolai, Dr. Krishna Kumar Rathnam
Myeloma Activities Chairpersons: Dr. Jeevan Kumar, Dr. Sumit Mirgh
12:35 - 12:50 IMF Activities Dr. Vincent Rajkumar
12:55 - 13:10 IMF Activities in Asia and AMN Clinical Trials Mr. Daniel Navid
13:15 - 13:30 IMAGe Activities, Consensus Guidelines Dr. Uday Yanamandra
Parallel session: 10:00 - 13:00 “Myeloma Awareness and Education: Q & A with National and International Experts” Venue : Premasharaya, DC Block, Action area-1, Newtown, Rajarhat, [opp: Tehno India College] West Bengal, Kolkata 700160
Break 13:00 - 14:00 Lunch with Mini - Oral paper presentation
14:00 - 15:30 ----- Chairpersons: Dr. Suresh Advani, Lt Gen (Dr) Velu Nair
14:00 - 14:30 TITLE: KEYNOTE Dr. Nikhil Munshi
14:30 - 15:30 INAUGURATION Dr. Pankaj/ Uday
Session 2: Plasma Cell Dyscrasia-Related Disorders Chairpersons: Dr. Prakash Chitalkar & Dr. Gurleen
15:30 – 15:45 Making Pathological Classification of MGRS Easy Dr. Rajan Duggal
15:50 – 16:05 Management of MGRS and Transplant in Myeloma with Renal Dysfunction Dr. Mammen Chandy
16:10 – 16:25 Current management of Waldenstrom Macroglobulinemia Dr. Prashant Kapoor
16:30 – 16:45 Myriad of manifestations in MGCS including POEMs Dr. Sundar Jagannath
16:50 – 17:30 Panel discussion on Dysproteinemias Moderator: Dr. Neeraj Siddharthan
Panelists: Dr. Anupama Borker, Dr. Aditya Jandial, Dr. Rajat Pincha, Dr. Khaliqur Rehman
16:00-16:30 Tea/Coffee
Session 3: 17:30-18:45 Best Oral Paper session Chairpersons: Brig S Das/ Dr Sadashivudu Gundeti
18:45 - 19:30 Industry Sponsored Session
End of Day 2 : Dinner
Day 3: (12-Jan-2025)
Session Time Topic Faculty Name
07.30 - 09.00 Quiz: Qualifying Teams Quiz Masters: Dr. Jasmita, Dr. Sumeet Mirgh
Session 1: Clinico-Pathological Case Discussion
09.00 - 09.45 Case presentation: Dr. Ritambhara Nada Discussant : Brig (Dr) Ranjith Nair
Session 2: Difficult to Diagnose and Treat Plasma Cell Dyscrasias Chairpersons: Dr. Sandeep Shah
09.45 - 10.10 Diagnosis, Risk stratification & Management of AL Amyloidosis Dr. Ashutosh Welchalekar
10.15 - 10.40 Management of extramedullary disease & Plasma Cell Leukemia Dr. Rahul Nathani
Session 3: Immune therapies, industry-sponsored symposium Chairpersons: Dr. Tapan Saikia & Dr. Shilpa Bhartia
10.45 - 11.00 Updates on Bispecific Antibodies in Multiple Myeloma TBA
11.05 - 11.20 Sequencing of CAR T cell therapies in management of RRMM Dr. Noopur Raje
11.20 - 12.00 Managing Toxicities of CAR’s and Bispecifics Across India: Making Expertise Available Moderator: Dr. Navin Khattry
Panelists: Dr. Rajib De, Dr. Rohit Chitrapur, Dr. Avinash Singh, Dr. Bhausaheb
Session 4: Precision therapy: Directions and Challenges Chairpersons: Dr. Debmalya
12.00 - 12.15 Precision therapy in Myeloma and the possibility of Cure Dr. Vincent Rajkumar
12.20 - 12.35 Physician’s take-away from the IMC 2025 & way forward in SAARC Nations Dr. Pankaj Malhotra
12.40 - 13.00 Valedictory and Vote of Thanks Dr. Mayur Parihar & Dr. Jeevan Kumar
End of Day 3 : LUNCH